PATEL JEEGAR PRAVINKUMAR (Chief Scientific Officer) sold 3.1% of their position (1.49K shares) of EVOMMUNE, INC. on the open market
Open‑market sale worth $33.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/25/2026ACC: 0002092017-26-000007
Officer· Chief Scientific Officer
Since Nov 2025
-1.49K
Net shares
Net seller
$33.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.49K acquired · 2.98K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.49K
Price / share
$3.84
Trade value
$5.71K
% of position
3.2%
6/22/2026
46.40K→47.89K
Common Stock
Direct
Shares
−1.49K
Price / share
$22.50
Trade value
$33.48K
% of position
3.1%
6/22/2026
47.89K→46.40K
Total
Net shares
+0.00
Net value
-$27.77K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/22/2026 | M · Option Exercise | +1.49K | $3.84 | $5.71K | 3.2% | 46.40K | 47.89K |
| Common Stock Direct | 6/22/2026 | S · Sale | −1.49K | $22.50 | $33.48K | 3.1% | 47.89K | 46.40K |
| Total | +0.00 | -$27.77K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
1.49K shares
Shares
−1.49K
Strike price
3.84
Held after
27.84K
Exercisable
—
6/22/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock1.49K shares | 6/22/2026 | M · Option Exercise | −1.49K | 3.84 | — | 27.84K |